cgs 15855a has been researched along with 3-methoxytyramine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altar, CA; Boyar, WC | 1 |
| Altar, CA; Boyar, WC; Oei, E; Wood, PL | 1 |
2 other study(ies) available for cgs 15855a and 3-methoxytyramine
| Article | Year |
|---|---|
Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Benzopyrans; Brain; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Homovanillic Acid; Kinetics; Male; Metoclopramide; Mice; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1987 |
Dopamine autoreceptors modulate the in vivo release of dopamine in the frontal, cingulate and entorhinal cortices.
Topics: Animals; Apomorphine; Benzopyrans; Caudate Nucleus; Dopamine; Frontal Lobe; Gyrus Cinguli; Limbic System; Male; Putamen; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1987 |